MJA
MJA

Subsidised access to TNFα inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?

Christine Y Lu, Kenneth M Williams, Lyn March, James V Bertouch and Richard O Day
Med J Aust 2004; 181 (8): . || doi: 10.5694/j.1326-5377.2004.tb06378.x
Published online: 18 October 2004

Christine Y Lu,* Kenneth M Williams,† Lyn March,‡ James V Bertouch,§ Richard O Day¶

Online responses are no longer available. Please refer to our instructions for authors page for more information.